HIV and liver disease forum: conference proceedings. Read more about HIV and liver disease forum: conference proceedings.
Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Read more about Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy.
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Read more about Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Read more about Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Read more about Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.
Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Read more about Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency.
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Read more about Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Read more about Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice.
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Read more about Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Read more about Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
